Department of Orthopaedics, Shanghai Key Laboratory for Prevention and Treatment of Bone and Joint Diseases, Shanghai Institute of Traumatology and Orthopaedics, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, 197 Ruijin 2nd Road, Shanghai 200025, PR China; Jiaxing Key Laboratory of Basic Research and Clinical Translation on Orthopedic Biomaterials, Department of Orthopaedics, the Second Affiliated Hospital of Jiaxing University, Jiaxing 314000, PR China.
Department of Orthopaedics, Shanghai Key Laboratory for Prevention and Treatment of Bone and Joint Diseases, Shanghai Institute of Traumatology and Orthopaedics, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, 197 Ruijin 2nd Road, Shanghai 200025, PR China.
Acta Biomater. 2024 Oct 15;188:406-419. doi: 10.1016/j.actbio.2024.09.008. Epub 2024 Sep 16.
Hydrogen (H₂) has great potential in the treatment of osteoarthritis, but its rapid diffusion and short retention time make it difficult to exert stable therapeutic effects. This study developed a short-fiber injectable material that can continuously generate hydrogen in situ to eliminate reactive oxygen species (ROS), alleviate oxidative stress and inflammation, and promote tissue repair. We prepared H-Si nanosheets with high hydrogen generation efficiency using a wet chemical exfoliation method and combined them with GelMA short fibers via electrospinning technology, achieving the in situ delivery of H-Si nanosheets and regulated hydrogen generation rate through the encapsulation and degradation of GelMA, ultimately achieving continuous and controlled hydrogen supply and stable therapeutic effects for osteoarthritis. In vitro and in vivo experiments confirmed the safety and efficacy of this material. The results showed that the material could continuously and efficiently generate hydrogen in simulated physiological environments (100 mg of material could generate 8.6 % hydrogen), effectively eliminate cellular reactive oxygen species (ROS positive rate reduced by 85.89 %), reduce cellular senescence and apoptosis (cell death rate decreased by 52 %, SA-βgal expression decreased by 78.3 %), promote normal chondrocyte function (Col II expression increased by 67.4 %, Ki67 expression increased by 87.5 %), and improve osteoarthritis in rats (OARSI score increased by 216 %). The in situ hydrogen generation and control system designed in this study provides a new method for the hydrogen's local and stable treatment of osteoarthritis. STATEMENT OF SIGNIFICANCE: Hydrogen (H₂) has great potential in the treatment of osteoarthritis by alleviating oxidative stress, but its rapid diffusion and short retention time make it difficult to exert stable therapeutic effects. This study introduces an innovative injectable material combining H-Si nanosheets and GelMA short fibers to address this issue. By enabling continuous in situ hydrogen generation, this material effectively eliminates reactive oxygen species, reduces oxidative stress and inflammation, and promotes tissue repair. In vitro and in vivo experiments demonstrate its high hydrogen generation efficiency, safety, and therapeutic efficacy, offering a promising new approach for osteoarthritis management.
氢气(H₂)在治疗骨关节炎方面具有巨大潜力,但其快速扩散和短保留时间使其难以发挥稳定的治疗效果。本研究开发了一种短纤维可注射材料,可原位持续产生氢气以消除活性氧(ROS),减轻氧化应激和炎症,并促进组织修复。我们使用湿法化学剥离法制备了具有高制氢效率的 H-Si 纳米片,并通过静电纺丝技术将其与 GelMA 短纤维结合,通过 GelMA 的封装和降解实现了 H-Si 纳米片的原位递送和调节氢气生成速率,最终实现了连续和可控的氢气供应以及骨关节炎的稳定治疗效果。体外和体内实验证实了该材料的安全性和有效性。结果表明,该材料可在模拟生理环境中持续高效地产生氢气(100mg 材料可产生 8.6%的氢气),有效消除细胞内的活性氧(ROS 阳性率降低 85.89%),减少细胞衰老和凋亡(细胞死亡率降低 52%,SA-βgal 表达降低 78.3%),促进正常软骨细胞功能(Col II 表达增加 67.4%,Ki67 表达增加 87.5%),改善大鼠骨关节炎(OARSI 评分增加 216%)。本研究设计的原位制氢与控制系统为氢气局部稳定治疗骨关节炎提供了新方法。